# ZUNVEYL
> **NDA218549** · New Drug Application · Sponsor: ALPHA COGNITION · Approved 2024-07-26
## Drug
- **FDA Application Number:** NDA218549
- **Application type:** New Drug Application
- **Brand name:** ZUNVEYL
- **Generic name:** BENZGALANTAMINE
- **Active ingredients:** BENZGALANTAMINE GLUCONATE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALPHA COGNITION
- **Manufacturer:** Alpha Cognition, Inc.
- **First approval:** 2024-07-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218549)
---
*AI Analytics · CC0 1.0*